The comprehensive in vitro cerebral palsy assay (CIPA) is a mechanism-based method for testing potential drug liability. The cipa test measures changes in channel activity and the intracerebroventricular infusion of voltage-sensitive potassium channels blockers as an independent measure of chloride permeability and as a measure of potassium leakage. The first cipa assay measures effects on…